Literature DB >> 16644885

Targeted screening for genetic haemochromatosis: a combined phenotype/genotype approach.

M Bhavnani1, D Lloyd, J Marples, K Pendry, M Worwood.   

Abstract

OBJECTIVE: To evaluate the clinical utility of a targeted screening approach for the detection of genetic haemochromatosis.
METHODS: Screening by measuring fasting serum transferrin saturation (TS) and gene testing was carried out in patients in whom a raised serum alanine amino transferase (ALT) activity and raised random serum TS had been found on routine blood testing.
RESULTS: During the 29 month study period, 32 patients homozygous for the C282Y genotype were detected from a catchment population of 330,000 by screening blood samples referred initially for routine laboratory liver function tests. By comparison, during the same period of time and within the same population, only seven patients were found by clinical suspicion alone. The patients in the study, after treatment by venesection, have shown both clinical and biochemical improvement.
CONCLUSIONS: The study shows that from a population of patients in whom a routine liver function profile had been requested, it is possible to detect subjects homozygous for the C282Y HFE genotype who have clinical or biochemical markers of iron overload.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16644885      PMCID: PMC1860286          DOI: 10.1136/jcp.2005.031898

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

2.  Prevalence of elevated serum transferrin saturation in adults in the United States.

Authors:  A C Looker; C L Johnson
Journal:  Ann Intern Med       Date:  1998-12-01       Impact factor: 25.391

3.  Rapid genetic screening for haemochromatosis using heteroduplex technology.

Authors:  H A Jackson; D J Bowen; M Worwood
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

Review 4.  Screening for hemochromatosis.

Authors:  C Q Edwards; J P Kushner
Journal:  N Engl J Med       Date:  1993-06-03       Impact factor: 91.245

5.  Long-term survival analysis in hereditary hemochromatosis.

Authors:  P C Adams; M Speechley; A E Kertesz
Journal:  Gastroenterology       Date:  1991-08       Impact factor: 22.682

6.  Hereditary haemochromatosis: only 1% of adult HFEC282Y homozygotes in South Wales have a clinical diagnosis of iron overload.

Authors:  C Anne McCune; Layla N Al-Jader; Alison May; Sara L Hayes; Helen A Jackson; Mark Worwood
Journal:  Hum Genet       Date:  2002-09-26       Impact factor: 4.132

Review 7.  Genetics of haemochromatosis.

Authors:  Adrian Bomford
Journal:  Lancet       Date:  2002-11-23       Impact factor: 79.321

8.  The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis.

Authors:  P C Adams; Y Deugnier; R Moirand; P Brissot
Journal:  Hepatology       Date:  1997-01       Impact factor: 17.425

Review 9.  Inherited iron loading: genetic testing in diagnosis and management.

Authors:  Mark Worwood
Journal:  Blood Rev       Date:  2005-03       Impact factor: 8.250

10.  Long-term survival in patients with hereditary hemochromatosis.

Authors:  C Niederau; R Fischer; A Pürschel; W Stremmel; D Häussinger; G Strohmeyer
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more
  2 in total

Review 1.  The myths and realities of hemochromatosis.

Authors:  Melanie D Beaton; Paul C Adams
Journal:  Can J Gastroenterol       Date:  2007-02       Impact factor: 3.522

2.  Screening for hemochromatosis by measuring ferritin levels: a more effective approach.

Authors:  Jill Waalen; Vincent J Felitti; Terri Gelbart; Ernest Beutler
Journal:  Blood       Date:  2007-11-19       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.